Main Industry
Biotechnology
Main Product/Service
Next-Generation DNA Synthesis: Development of next-generation enzymatic DNA and RNA synthesis reagents and technology platforms, rapid nucleic acid labeling platforms, and biomedical and biotechnology applications.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2019
Unified Business No.
54978743
Status
Active
Number of Employees
0
Total Paid-in
Capital
165,145,986 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Yuan-Dian Biotechnology is dedicated to the development of next-generation DNA synthesis (Next-Generation DNA Synthesis) technologies and platforms. We create applications for DNA in the biotechnology and biomedical industries through innovations in basic science. Yuan-Dian Biotech has broken through the highly challenging bottlenecks of traditional chemical DNA synthesis technology, establishing and validating a new generation of enzymatic DNA synthesis (Enzymatic DNA Synthesis) technology and platform. This technology and platform will greatly improve the efficiency and cost of current oligonucleotide and probe synthesis (oligonucleotide & Probe Synthesis), making DNA reading (Sequencing) and writing (Synthesis) faster and more accessible. The extension of this technology will accelerate innovations in personalized precision medicine, the development of novel nucleic acid and protein vaccines, gene editing and the improvement of animal and plant genomes, applications of synthetic biology, and even the commercialization of DNA-based big data storage and computing. The resulting industrial transformation will span healthcare, biotechnology, agriculture, energy, information technology, and more.
(The content above was translated by AI.)
(The content above was translated by AI.)
